AstraZeneca GmbH secures contract for Pharmaceutical products - drug discount agreement in accordance with Section 130c Paragraph 1 SGB V i V m Section 130a Paragraph 8 SGB V for the active ingredient Tezepelumab

Germany, Oct. 12 -- Germany based AstraZeneca GmbH has secured contract from AOK Baden-Wurttemberg for Pharmaceutical products - drug discount agreement in accordance with Section 130c Paragraph 1 SGB V i V m Section 130a Paragraph 8 SGB V for the active ingredient Tezepelumab. The value of the contract is not disclosed.

Published by HT Digital Content Services with permission from Pivotal Sources....